Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
01 7Evonik
02 1Faran Shimi Pharmaceutical
03 2Aeon Procare
04 3Alcedo Pharmachem
05 12BASF
06 3Finar
07 2Gangwal Chemicals
08 5Ideal Cures Pvt Ltd
09 14Kerry
10 1Kima Chemical
11 1Lonza Capsugel
12 2Pluviaendo
13 2The Dow Chemical Company
14 3Vertellus
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Potassium Chloride
Application : Parenteral
Excipient Details : Potassium chloride is used as a diuretic-osmotic in injectable and parenteral solutions.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Injectable / Parenteral
Category : Parenteral
Brand : POTASSIUM CHLORIDE
Applications : Potassium chloride is used as a diuretic-osmotic in injectable and parenteral solutions.
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Parenteral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Copolymer Type B
Category : Controlled & Modified Release
Brand : EUDRAGIT® S 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
